in

SEG 2020 Annual Software Industry Report

Software industry public stock market and M&A valuations reached record peaks yet again in 2019. This was led by investor and buyer interest in publicly traded SaaS companies (8.2x EV/Revenue) and SaaS M&A targets (4.9x EV/Revenue). M&A deal activity also reached record levels in 2019, as SaaS M&A volume grew 27% during the year.

Keep on reading: SEG 2020 Annual Software Industry Report





in

SaaS Key Performance Indicator Index – An Operational Perspective

Over the last twenty years, SaaS investors and executives alike have done a great job at defining, evolving and managing to Key "Enterprise Valuation" Indicators such as Customer Acquisition Cost (CAC), Customer Acquisition Cost Ratio, Customer Lifetime Value (CLTV), CMRR/ARR, Gross Margin, Gross and Net Churn, and of course, the "Rule of 40".   Several industries influencers, such as Pacific Crest (Key Bank Capital Markets), OpenView, Insight Partners and KPMG, to name just a few, have done ...

Keep on reading: SaaS Key Performance Indicator Index – An Operational Perspective




in

Bien manger en famille durant le confinement

Conseils de pro pour continuer à bien manger en temps de confinement.




in

Bon stress, Bad stress: un cercle infernal

Jean-Yves Dionne explique ce qu’est le stress – le bon comme le moins bon – et propose des façons de mieux le gérer.




in

Industrial AI Consortium Note

With a mission to make India to among the top 3 Industrial AI hubs in the world by 2021, Flutura Co-Founder, Derick Jose, shares a crisp note which outlines the journey so far and the vision going forward.

Keep on reading: Industrial AI Consortium Note





in

Amazon 2018: Bulldozing More Market Leaders

A look at technology business trends for 2018 and beyond shows Amazon’s market-munching power shows no sign of waning.

Keep on reading: Amazon 2018: Bulldozing More Market Leaders






in

M.R. Asks 3 Questions: Philippe Bouissou, Ph.D., Managing Partner, Blue Dots Partners LLC.

For those of you who find yourselves with more time to read over the next few weeks, Managing Partner at Blue Dots Partners LLC., Philippe Bouissou, Ph.D., explains how his research and strategies help businesses stay aligned while working to survive a time of uncertainty.

Keep on reading: M.R. Asks 3 Questions: Philippe Bouissou, Ph.D., Managing Partner, Blue Dots Partners LLC.





in

To CIOs: A message from your engine room

CIOs often end up trying to manage complex browsers with traditional management or cobbled-together tools. Why is this a problem?

Keep on reading: To CIOs: A message from your engine room




in

Presenting the Internet of “Security” Things

A closer look at the strategic technical developments aimed at improving mobile data security and endpoint experience.

Keep on reading: Presenting the Internet of “Security” Things




in

Growth Players: CellPoint Mobile’s CEO Kristian Gjerding

Aiming to enable a “nirvana” experience for travelers has driven CellPoint towards block-chain powered, biometric-enabled identification.

Keep on reading: Growth Players: CellPoint Mobile’s CEO Kristian Gjerding




in

Why End-User Computing Needs a Refresh

The anticipated proliferation of devices demands an innovative approach to managing, securing and delivering these endpoints and the applications that will run on them.

Keep on reading: Why End-User Computing Needs a Refresh




in

6 Headlines from the 2019 Mobile World Conference

The 2019 Mobile World Conference was held in Barcelona, featuring extensive learning opportunities from dozens of partner-led programmes, GSMA seminars, summits and more. Here are four notable headlines from this year's conference that you might have missed.

Keep on reading: 6 Headlines from the 2019 Mobile World Conference




in

'Technical issues' in labs blamed for testing failures

The government has blamed "technical issues" in labs for its failure to reach its coronavirus test target for four consecutive days.




in

'Very limited' lockdown changes in England next week - Downing Street

Lockdown changes in England from next week will be "very limited", Boris Johnson's spokesman has confirmed.




in

Scotland lockdown 'must be extended' - easing it 'very risky', Sturgeon says

The coronavirus lockdown "must be extended" in Scotland and easing any restrictions would be "very, very risky", Nicola Sturgeon has announced.




in

Easing the lockdown: What might change - if anything - on Monday?

Boris Johnson will on Sunday set out the government's plan for lifting coronavirus lockdown measures.




in

Coronavirus: PM seeks to convince bosses over lockdown easing

Boris Johnson will seek to persuade Britain's top bosses on Sunday that his strategy for easing the coronavirus lockdown will pave the way for a swift economic fightback.




in

Marking VE Day, PM tells veterans: 'You will always be remembered'

Boris Johnson has declared that the UK's response to the coronavirus demands the same effort and courage as the armed forces showed in the Second World War.




in

No 'dramatic overnight change' planned for UK's lockdown, minister warns

There will not be any "dramatic overnight change" of the UK's lockdown rules, a cabinet minister has warned.




in

Face-Aging Selfies Help Modify Risky Skin Behaviors for Teens

(MedPage Today) -- Witnessing ultraviolet (UV) radiation-induced facial aging firsthand may be a useful tool to convince youth to slather on the sunscreen, a new study suggested. In a randomized trial of high school teens in southeast Brazil...




in

COVID-19 Update: CDC Reopening Plan Shelved; Trump Exposed Again?

(MedPage Today) -- Note that some links may require registration or subscription. The Trump administration has decided not to implement a CDC-backed plan to reopen America, including step-by-step advice for mass transit, day care facilities, schools...




in

Force-Sensing Ablation Catheter Makes Headway in Persistent Afib

(MedPage Today) -- Outcomes after radiofrequency (RF) ablation with a contact force-sensing catheter were promising for people with persistent atrial fibrillation (Afib) in the PRECEPT study. The device yielded 61.7% freedom at 15 months from...




in

COVID-19 Testing Lags in Prisons and Jails

(MedPage Today) -- This story, the second on incarcerated individuals, is part of a MedPage Today series examining the impact of COVID-19 on vulnerable populations. Previous reports focused on the homeless, immigrants in detention, the undocumented...




in

REACH2 Highlights Efficacy of JAK1/2 Inhibitor vs Standard Care for Acute GVHD

(MedPage Today) -- Study Authors: Robert Zeiser, Nikolas von Bubnoff, et al.; Nelson Chao Target Audience and Goal Statement: Oncologists, hematologists The goal of this study was to determine the benefit/risk profile of the Janus kinase (JAK...




in

Rheumatoid Arthritis Triple Therapy Little Used in U.S.

(MedPage Today) -- Triple therapy -- with methotrexate, hydroxychloroquine, and sulfasalazine -- is little used for the treatment of rheumatoid arthritis (RA) in the U.S. today, and clinical outcomes showed less efficacy than regimens combining...




in

Kawasaki Disease From COVID-19 in Kids: How Common?

(MedPage Today) -- As health organizations have started warning about unusual presentations of a Kawasaki disease-like inflammatory syndrome associated with COVID-19, some pediatric cardiologists noted that even classic cases are likely going undercounted...




in

Ethics Consult: Recommend COVID Patients Enroll in Drug Trial?

(MedPage Today) -- You make the call




in

Study Backs Cytokine Targeting for COVID-19 Tx

(MedPage Today) -- Survival rates were significantly higher, though mechanical ventilation-free survival did not differ between hospitalized COVID-19 patients treated with high-dose anakinra (Kineret), an interleukin-1 receptor antagonist, and...




in

Promise of T1D Vaccines; Can Bariatric Surgery Be Essential?

(MedPage Today) -- Researchers developed a potential vaccine for a certain type of virus infection that leads to an autoimmune attack, which may result in turn in part to the development of type 1 diabetes. "Our hope is that these trials will show...




in

Three Drugs Better Than One in Hospitalized COVID-19 Patients

(MedPage Today) -- Patients hospitalized with COVID-19 who received a combination therapy with three antivirals -- protease inhibitor lopinavir-ritonavir (Kaletra), nucleoside analogue ribavirin, and injectable interferon beta-1b (Betaseron...




in

'It was bananas': Crowds swarm to shopping centres causing alarm over lack of social distancing

Huge crowds flocked to shopping centres across Australia in a pre-Mother's Day rush which was good news for the retail industry, but set off alarm bells for a potential coronavirus spike, with one shopper describing the scenes like "swimming in a COVID soup".




in

A Republican Crusader Takes on Oklahoma’s Prison Machine

In the state that locks up more of its citizens than any other, a former politician is using the ballot box—and some surprising alliances—to nudge his own party toward change.




in

A Second Covid Crisis Is Coming

If we don’t act now, women and girls will be suffering from the pandemic’s fallout for decades to come.




in

‘Smoke-Filled Zoom’: Handicapping Trump vs. Biden in the Middle of a Lockdown

Four veteran GOP campaign managers gathered—virtually—to predict an unprecedented race that’s been blindsided by a pandemic and an economic collapse.




in

Here’s How to Cover Uninsured Americans During the Pandemic

Empowering Medicare to cover our health needs is comprehensive and cost-effective.




in

No, the Media Isn’t Burying the Biden Allegations

Despite the critics, there’s been wide coverage of a story that may never be more than he-said, she-said. Now, when will the VP face the question?




in

Admit It: You Are Willing to Let People Die to End the Shutdown

The question is how many and how soon. In the pandemic, everyone is a moral relativist.




in

Justin Amash Wants to Destroy the System that Created Trump

But critics fear his third-party White House bid will only serve to reelect the president.




in

‘Not the World’s Number One’: Chinese Social Media Piles On the U.S.

The verdict is in: China has outperformed, while the once-respected American system has disastrously faltered.




in

The Mountain County That Went into Coronavirus Lockdown

When rural America confronts the pandemic, it faces a different set of challenges.




in

The Women of Maine vs. Susan Collins

The senior senator faces an especially difficult reelection challenge. Did she change or did her voters?




in

What’s Behind China’s New Behavior in Europe

In ramping up diplomatic pressure, China is trying to control the narrative of the pandemic.




in

Experts Knew a Pandemic Was Coming. Here’s What They’re Worried About Next.

Nine disasters we still aren’t ready for.




in

Do not risk more Labor power sharing

ERIC ABETZ: It is all the way with the Liberal Coalition or disaster.




in

Major win for regions

TASMANIA is set to benefit from a major overhaul of a fund that was supposed to ­provide vital projects and ­infrastructure to Australia’s ­regions — but instead pumped millions into mainland capital cities.